-SEC Filing
Sorrento Therapeutics Starts Large Efficacy Trial For Intranasal COVID-19 Antibody In UK
The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) signed off Sorrento Therapeutics Inc’s (NASDAQ:SRNE) Phase 2 trial evaluating COVI-DROPS in…